http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2292881-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2c41f097dabca4bee37ddc61d913848 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 |
| filingDate | 2002-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_505270aa3a7aaaabda9655deaabdde59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71519f466cfea417a37b0af3fee4d839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a35b0c4b7e6fa822fec0d3efa095a57d |
| publicationDate | 2007-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2292881-C2 |
| titleOfInvention | Carbamate compounds for using in prophylaxis or treatment of anxiety disorders |
| abstract | FIELD: organic chemistry, medicine, clinical pharmacology, pharmacy. n SUBSTANCE: invention relates to using a compound chosen from a group consisting of compound of the formula (I) and the formula (II) , an enantiomer chosen from a group consisting of compounds of the formula (I) and the formula (II), or mixture of enantiomers wherein one of an enantiomer prevails chosen from a group consisting of compounds of the formula (I) and the formula (II) used for manufacturing a pharmaceutical composition used in prophylaxis or treatment of the anxiety disorder. One of enantiomers can prevail in the composition and chosen from a group consisting of compounds of the formula (I) and the formula (II) with their content about 90%, 98% or above. Pharmaceutical compositions are designated for using in broad spectrum of anxiety disorders of different genesis. n EFFECT: valuable medicinal properties of compounds and pharmaceutical composition. n 19 cl |
| priorityDate | 2001-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.